Verona Pharma (VRNA)

P/S ratio as of February 2025 (TTM): 973

According to Verona Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 41.9. At the end of 2024 the company had a P/S ratio of 415.

P/S ratio history for Verona Pharma from 2021 to 2020

PS ratio at the end of each year

Year	P/S ratio	Change
2024	415
2023	N/A	-100%
2022	> 1000	42694.69%
2021	10.1
2020	N/A
2019	N/A
2018	N/A
2017	N/A	-100%
2016	6.89

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
NRC Health NRC	2.52	-99.74%	🇺🇸 USA
Nymox Pharmaceutical NYMX	N/A	N/A	Bahamas

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Verona Pharma (VRNA)

P/S ratio as of February 2025 (TTM): 973